{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:16:29Z","timestamp":1784891789829,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700251"],"award-info":[{"award-number":["81700251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.yjmcc.2019.04.011","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T05:43:28Z","timestamp":1555307008000},"page":"170-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy"],"prefix":"10.1016","volume":"130","author":[{"given":"Guang-Feng","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Lin","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2019.04.011_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0010","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.2337\/db13-1577","article-title":"Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy","volume":"63","author":"Pan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0015","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00125-017-4232-4","article-title":"CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats","volume":"60","author":"Ma","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0020","doi-asserted-by":"crossref","first-page":"35618","DOI":"10.18632\/oncotarget.8343","article-title":"Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jdiacomp.2008.02.009","article-title":"Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat","volume":"23","author":"Shirpoor","year":"2009","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0030","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jcp.22847","article-title":"NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-kappaB in cardiomyocytes exposed to high glucose","volume":"227","author":"Tsai","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0035","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.2337\/db11-0263","article-title":"Elevated NF-\u03baB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase","volume":"60","author":"Green","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cvr\/cvp305","article-title":"NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes","volume":"85","author":"Mariappan","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0045","doi-asserted-by":"crossref","first-page":"33197","DOI":"10.18632\/oncotarget.16593","article-title":"(DEAD)-box RNA helicase 3 modulates NF-\u03baB signal pathway by controlling the phosphorylation of PP2A-C subunit","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0050","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/cdd.2008.98","article-title":"Identification of PP2A as a crucial regulator of the NF-\u03baB feedback loop: its inhibition by UVB turns NF-\u03baB into a pro-apoptotic factor","volume":"15","author":"Barisic","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086234","article-title":"Regulation of PP2AC carboxylmethylation and cellular localisation by inhibitory class G-protein coupled receptors in cardiomyocytes","volume":"9","author":"Longman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0060","first-page":"167","volume":"243","author":"Ivabradine","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2261-14-150","article-title":"I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0070","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1111\/bph.13220","article-title":"Pleiotropic, heart rate-independent cardioprotection by ivabradine","volume":"172","author":"Kleinbongard","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.111.183913","article-title":"Role of heart rate reduction in the prevention of experimental heart failure: comparison between if-channel blockade and \u03b2-receptor blockade","volume":"59","author":"Becher","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2016.03.025","article-title":"Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties","volume":"428","author":"Khan","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0085","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.biopha.2016.10.074","article-title":"Dendrobium officinale Kimura et Migo attenuates diabetic cardiomyopathy through inhibiting oxidative stress, inflammation and fibrosis in streptozotocin-induced mice","volume":"84","author":"Zhang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.02.029","article-title":"EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model","volume":"82","author":"Liang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-016-2716-z","article-title":"Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy","volume":"417","author":"Zhang","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0100","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/ehs218","article-title":"Heart rate reduction by if-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction","volume":"34","author":"Reil","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.04.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-014-0460-7","article-title":"Heart rate reduction and longevity in mice","volume":"110","author":"Gent","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0115","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1325671","article-title":"Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation","volume":"257","author":"Chen","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yjmcc.2013.10.014","article-title":"The interplay between autophagy and apoptosis in the diabetic heart","volume":"71","author":"Ouyang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","article-title":"Diabetic cardiomyopathy-fact or fiction?","volume":"36","author":"Maisch","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0140","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.04.011_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virol.2016.12.022","article-title":"NF-\u03baB activation is cell type-specific in the heart","volume":"502","author":"Rivera-Serrano","year":"2017","journal-title":"Virology"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282819300628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282819300628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T10:19:26Z","timestamp":1607249966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282819300628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":29,"alternative-id":["S0022282819300628"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.011","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}